Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Immix, PDS, Rapt, Rocket.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annovis, Apnimed, Cytomx, Fate, Freeline, Innovent, Merck & Co., Oculis, Onechain, Tscan.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acepodia, Acumen, Aldeyra, Alkeus, Alterity, Annexon, Compass, Cytokinetics, Decibel, Fulcrum, Leo, Neushen, Nxera, Pfizer, Regeneron, Telios, Teva, Tiumbio, Umecrine, Xinnate.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Calliditas, Eledon, Eyedna, Inmagene, Mirum, Moleculin, Neurogene, Neurosense, Rion, Traws, Verve.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Asclepix, Biomarin, Boehringer, Edgewise, Eyepoint, Ferring, Glycomimetics, Impact, Inmagene, Janssen, Johnson & Johnson, Kiora, Lineage, Lyra, Mind Medicine, Roche, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aeon, Gossamer, Hanall, Kancera, Ventus, Xylocor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allarity, Alpha-9, Alx Oncology, Alzheon, Annovis, Astrazeneca, Bio-gene, Corcept, Eagle, Emmecell, Galecto, Immunic, Immutep, In8bio, Newron, Nrx, Organogenesis, Polypid, Remix, Renovion, Rhythm, Smart Immune, Soleno, Stalicla, Sutro, TFF Pharmaceuticals, Ultragenyx, Veru.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alumis, Arsenal, Aurion, Biora, Debiopharm, Foresee, Inmune, Mannkind, Nacuity, Nanoviricides, Recce, Repare, Terns, Vaxart.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Aim, Astrazeneca, Bitterroot, Cognition, Inflammasome, Inmune, Intellia, Merck & Co., Selection.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Arbele, Biocardia, Caliway, Can-Fite, Nkgen, Recce.